Cargando…
Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030095/ https://www.ncbi.nlm.nih.gov/pubmed/24855178 http://dx.doi.org/10.2337/dc13-2473 |
| _version_ | 1782317330638831616 |
|---|---|
| author | Goodarzi, Mark O. |
| author_facet | Goodarzi, Mark O. |
| author_sort | Goodarzi, Mark O. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4030095 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40300952015-06-01 Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987 Goodarzi, Mark O. Diabetes Care e-Letters: Comments and Responses American Diabetes Association 2014-06 2014-05-10 /pmc/articles/PMC4030095/ /pubmed/24855178 http://dx.doi.org/10.2337/dc13-2473 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | e-Letters: Comments and Responses Goodarzi, Mark O. Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987 |
| title | Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987 |
| title_full | Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987 |
| title_fullStr | Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987 |
| title_full_unstemmed | Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987 |
| title_short | Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987 |
| title_sort | comment on moore et al. increased risk of cognitive impairment in patients with diabetes is associated with metformin. diabetes care 2013;36:2981–2987 |
| topic | e-Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030095/ https://www.ncbi.nlm.nih.gov/pubmed/24855178 http://dx.doi.org/10.2337/dc13-2473 |
| work_keys_str_mv | AT goodarzimarko commentonmooreetalincreasedriskofcognitiveimpairmentinpatientswithdiabetesisassociatedwithmetformindiabetescare20133629812987 |